Home › Research › Vascular contributions
Cerebral small vessel disease: The impact of glymphopathy and sleep disorders
Zaw Myo Hein, Che Mohd Nasril Che Mohd Nassir, Muhammad Danial Che Ramli, Usman Jaffer, Muhammad Zulfadli Mehat, Muzaimi Mustapha, Hafizah Abdul Hamid. Journal of Cerebral Blood Flow & Metabolism, 2025-05-05
Topic: Brain proteins, microglia and lab models
Plain-language summary
The glymphatic system, a vital brain perivascular network for waste clearance, hinges on the functionality of the aquaporin 4 (AQP4) water channel. Alarmingly, AQP4 single nucleotide polymorphisms (SNPs) are linked to impaired glymphatic clearance, or glymphopathy, which contributes to sleep disturbances and various age-related neurodegenerative diseases. Despite the critical role of glymphopathy and sleep disturbances in cerebral small vessel disease (CSVD) - a silent precursor to age-related neurodegenerative disorders - their interplay remains underexplored. CSVD is a major cause of stroke and dementia, yet its pathogenesis is not fully understood. Emerging evidence implicates glymphopathy and sleep disorders as pivotal factors in age-related CSVD, exacerbating the condition by hindering waste removal and compromising blood-brain barrier (BBB) integrity. Advanced imaging techniques promise to enhance diagnosis and monitoring, while lifestyle modifications and personalised medicine present promising treatment avenues. This narrative review underscores the need for a multidisciplinary approach to understanding glymphopathy and sleep disorders in CSVD. By exploring their roles, emphasising the necessity for longitudinal studies, and discussing potential therapeutic interventions, this paper aims to pave the way for new research and therapeutic directions in CSVD management.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. These are proposed directions requiring further study, not established treatments, cures, or prevention for Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hein, Z. M., Nassir, C. M. N. C. M., Ramli, M. D. C., Jaffer, U., Mehat, M. Z., Mustapha, M., et al. (2025). Cerebral small vessel disease: The impact of glymphopathy and sleep disorders. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x251333933
Vancouver
Hein ZM, Nassir CMNCM, Ramli MDC, Jaffer U, Mehat MZ, Mustapha M, et al. Cerebral small vessel disease: The impact of glymphopathy and sleep disorders. Journal of Cerebral Blood Flow & Metabolism. 2025. doi:10.1177/0271678x251333933. PMID: 40322968.
BibTeX
@article{hein2025-40322968,
author = {Hein, Zaw Myo and Nassir, Che Mohd Nasril Che Mohd and Ramli, Muhammad Danial Che and Jaffer, Usman and Mehat, Muhammad Zulfadli and Mustapha, Muzaimi and Hamid, Hafizah Abdul},
title = {{Cerebral small vessel disease: The impact of glymphopathy and sleep disorders}},
journal = {Journal of Cerebral Blood Flow \& Metabolism},
year = {2025},
doi = {10.1177/0271678x251333933},
pmid = {40322968},
url = {https://doi.org/10.1177/0271678x251333933}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- CSVD is a major cause of stroke and dementia, yet its pathogenesis is not fully understood.
- Emerging evidence implicates glymphopathy and sleep disorders as pivotal factors in age-related CSVD, exacerbating the condition by hindering waste removal and compromising blood-brain barrier (BBB) integrity.
- Advanced imaging techniques promise to enhance diagnosis and monitoring, while lifestyle modifications and personalised medicine present promising treatment avenues.
- This narrative review underscores the need for a multidisciplinary approach to understanding glymphopathy and sleep disorders in CSVD.
- By exploring their roles, emphasising the necessity for longitudinal studies, and discussing potential therapeutic interventions, this paper aims to pave the way for new research and therapeutic directions in CSVD management.
Why it matters
This narrative review discusses how glymphatic dysfunction and sleep disorders may contribute to cerebral small vessel disease by hindering waste removal and compromising blood-brain barrier integrity, and it suggests lifestyle modifications and personalized medicine as possible treatment avenues. These are proposed directions requiring further study, not established treatments, cures, or prevention for Alzheimer's disease.
Study details
- Study designlongitudinal study
- Evidence strengthModerate
How this study scored 47/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Cerebral Blood Flow & Metabolism) |
| Journal's citation record | 3 / 4 | Journal of Cerebral Blood Flow & Metabolism: journal h-index 285 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 8 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Hafizah Abdul Hamid: h-index 13 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Universiti Sains Malaysia: institution h-index 482 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40322968) |
| Free to read | 2 / 2 | Free to read |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Vascular contributions from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.